Klingman & Associates LLC Sells 147 Shares of UnitedHealth Group Incorporated $UNH

Klingman & Associates LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,159 shares of the healthcare conglomerate’s stock after selling 147 shares during the quarter. Klingman & Associates LLC’s holdings in UnitedHealth Group were worth $362,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. DekaBank Deutsche Girozentrale raised its stake in shares of UnitedHealth Group by 1.1% in the second quarter. DekaBank Deutsche Girozentrale now owns 936,422 shares of the healthcare conglomerate’s stock worth $291,636,000 after buying an additional 10,633 shares during the period. Princeton Global Asset Management LLC raised its stake in shares of UnitedHealth Group by 96.7% in the second quarter. Princeton Global Asset Management LLC now owns 474 shares of the healthcare conglomerate’s stock worth $148,000 after buying an additional 233 shares during the period. Crewe Advisors LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $214,000. Alan B Lancz & Associates Inc. bought a new position in shares of UnitedHealth Group in the second quarter worth about $407,000. Finally, Sentry Investment Management LLC raised its stake in shares of UnitedHealth Group by 38.4% in the second quarter. Sentry Investment Management LLC now owns 4,170 shares of the healthcare conglomerate’s stock worth $1,283,000 after buying an additional 1,157 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $365.47 on Wednesday. The stock has a market cap of $331.00 billion, a price-to-earnings ratio of 15.83, a price-to-earnings-growth ratio of 2.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a 50 day moving average price of $333.70 and a 200-day moving average price of $341.28. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on UNH. Morgan Stanley increased their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Jefferies Financial Group increased their target price on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price for the company. Robert W. Baird restated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Finally, Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and a consensus target price of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.